P3 Health Partners (PIII) Competitors

DocGo (NASDAQ:DCGO) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

Is DCGO or PIII more profitable?

DocGo has a net margin of -0.12% compared to P3 Health Partners' net margin of -9.27%. DocGo's return on equity of 2.52% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-0.12%	2.52%	1.70%
P3 Health Partners	-9.27%	-123.10%	-15.94%

Which has higher valuation & earnings, DCGO or PIII?

DocGo has higher earnings, but lower revenue than P3 Health Partners. DocGo is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$616.55M	0.26	$19.99M	-$0.02	-79.25
P3 Health Partners	$1.50B	0.03	-$135.85M	-$47.28	-0.13

Do institutionals and insiders have more ownership in DCGO or PIII?

56.4% of DocGo shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 2.7% of DocGo shares are owned by company insiders. Comparatively, 17.8% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media refer more to DCGO or PIII?

In the previous week, DocGo had 4 more articles in the media than P3 Health Partners. MarketBeat recorded 5 mentions for DocGo and 1 mentions for P3 Health Partners. DocGo's average media sentiment score of 0.93 beat P3 Health Partners' score of 0.00 indicating that DocGo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer DCGO or PIII?

DocGo presently has a consensus price target of $3.56, suggesting a potential upside of 124.61%. P3 Health Partners has a consensus price target of $16.25, suggesting a potential upside of 155.30%. Given P3 Health Partners' higher possible upside, analysts plainly believe P3 Health Partners is more favorable than DocGo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
P3 Health Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has more risk & volatility, DCGO or PIII?

DocGo has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.

Summary

DocGo beats P3 Health Partners on 11 of the 15 factors compared between the two stocks.